Foscarnet

From Citizendium
Revision as of 14:08, 28 March 2008 by imported>David E. Volk
Jump to navigation Jump to search
This article is developed but not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable, developed Main Article is subject to a disclaimer.
Foscarnet.jpg
foscarnet
IUPAC name: phosphonoformic acid
Synonyms: see list below
Formula: CH3O5P

 Uses: treatment of CMV retinitis, herpes and HIV.

 Properties: antiviral agent

 Hazards: see drug interactions

Mass (g/mol): CAS #:
126.0053 63585-09-1


Foscarnet is an antiviral drug used to treat retinitis due to cytomegalovirus (CMV) and acyclovir-resistant herpes simplex virus (HSV-1 & HSV-2) infections in patients with compromised immune systems, often associated with AIDS.


Chemistry

Foscarnet is a carboxylic acid-based organic mimic of the natural inorganic compound pyrophosphate. The chemical name of foscarnet is phosphonoformic acid and it has chemical formula CH3O5P, giving it a molecular mass of 126.0053 g/mol. Being already phosphorylated, foscarnet does not need to be phosphorylated to become active. Becuase of this, viral strains resistant to acyclovir or ganciclovir, associated with thymidine kinase deficiency, may be treatable with foscarnet. Foscarnet and related compounds, like phosphonoacetic acid (PAA), can be synthesized by reacting chloroformic acid esters with phosphites ([the [Arbuzov reaction]])[1]

Mechanism of action

Foscarnet binds to pyrophosphate binding sites of DNA polymerases and thus inhibits the production of viral DNA by blocking the energy source (pyrophosphate) from reaching the viral polymerases. Cellular DNA polymerases are not effected by the dosages at foscarnet is taken.


Synonyms and brand names

Synonyms

  • PFA
  • Foscarnet sodium
  • Forscarnet sodium
  • Dihydroxyphosphinecarboxylic acid oxide
  • Carboxyphosphonic acid
  • Phgosphonocarboxylic acid
  • Phosphonoformate
  • Phosphonoformic acid

Brand names

  • Foscarmet®
  • Foscavir®
  • Triapten®
  1. Noren, Helgstrand, Johansson, Misiorny and Stening. "{{{title}}}". J. Med. Chem. 26: 264-270. [1]